Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | DHCR24 | Q15392 | 10/20 | 0.77 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | NPC1L1 | Q9UHC9 | 1/20 | 0.51 |
| ▸ | RORC | P51449 | 2/20 | 0.50 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.50 |
| ▸ | OSBP | P22059 | 1/20 | 0.50 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.50 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | CYP8B1 | Q9UNU6 | 1/20 | 0.48 |
| ▸ | GPR183 | P32249 | 1/20 | 0.46 |
| ▸ | RORA | P35398 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22099724 | 1.00 | USP2 (1.00) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL187737 | 1.00 | USP2 (1.00) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL14360754 | 1.00 | USP2 (1.00) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL28606202 | 1.00 | USP2 (1.00) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL1957035 | 1.00 | USP2 (1.00) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL15529878 | 1.00 | USP2 (1.00) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL25035233 | 1.00 | USP2 (1.00) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL28186368 | 0.92 | MEN1 (0.85) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL2396787 | 0.91 | MEN1 (0.83) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL12869831 | 0.91 | MEN1 (0.83) | USP2MEN1KMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040048838-A1 | Meiosis regulating compounds | GRONVALD FREDERIK CHRISTIAN (DK) | 2004-03-11 | — | — | US | claimed |
| US-20020013302-A1 | Meiosis regulating compounds | NOVO NORDISK A/S (DK) | 2002-01-31 | — | — | US | claimed |
| EP-0857173-A1 | MEIOSIS REGULATING COMPOUNDS | NOVO NORDISK A/S (DK) | 1998-08-12 | — | — | EP | claimed |
| WO-1997000884-A1 | MEIOSIS REGULATING COMPOUNDS | NOVO NORDISK A/S (DK) | 1997-01-09 | — | — | WO | claimed |
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | THE BROAD INSTITUTE, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-20250376656-A1 | MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-12-11 | — | — | US | disclosed |
| US-20250319190-A1 | APOE LIPOPROTEIN SYSTEMS | KISBEE THERAPEUTICS INC (US) | 2025-10-16 | — | — | US | disclosed |
| EP-4522646-A2 | APOE LIPOPROTEIN SYSTEMS | Kisbee Therapeutics, Inc. (US) | 2025-03-19 | — | — | EP | disclosed |
| CN-118973585-A | DHCR24 inhibiting compounds | 莱顿教学医院 | 2024-11-15 | — | — | CN | disclosed |
| WO-2023220387-A2 | APOE LIPOPROTEIN SYSTEMS | KISBEE THERAPEUTICS, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| US-20220228190-A1 | MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-07-21 | — | — | US | disclosed |
| US-20200109163-A1 | CARBONATED BEVERAGE AND METHOD FOR CARBONATION ENHANCEMENT | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2020-04-09 | — | — | US | disclosed |
| US-20040048838-A1 | Meiosis regulating compounds | GRONVALD FREDERIK CHRISTIAN (DK) | 2004-03-11 | — | — | US | disclosed |
| US-20030220314-A1 | Dehydro-estriol (8-DHE3) and dehydro-pregnanetriol (7-DHPT), and methods of their synthesis | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-11-27 | — | — | US | disclosed |
| US-6645953-B2 | Sterol derivative compounds, structurally related to natural compounds which can be extracted from bull testes and from human follicular fluid, for regulating meiosis in oocytes and in male germ cells; use in treating infertility, | NOVO NORDISK A/S (DK) | 2003-11-11 | — | — | US | disclosed |
| EP-0767798-B1 | STEROL DERIVATIVES USED FOR REGULATION OF MEIOSIS | NOVO NORDISK AS (DK) | 2003-09-03 | — | — | EP | disclosed |
| US-20020013302-A1 | Meiosis regulating compounds | NOVO NORDISK A/S (DK) | 2002-01-31 | — | — | US | disclosed |
| EP-0857173-A1 | MEIOSIS REGULATING COMPOUNDS | NOVO NORDISK A/S (DK) | 1998-08-12 | — | — | EP | disclosed |
| US-5716777-A | REGULATING MEIOSIS IN MAMMALIAN GERM CELL BY ADMINISTERING SPECIFIED STEROL IN VITRO | NOVO NORDISK A/S (DK) | 1998-02-10 | — | — | US | disclosed |
| WO-1997000884-A1 | MEIOSIS REGULATING COMPOUNDS | NOVO NORDISK A/S (DK) | 1997-01-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220314-A1 | Dehydro-estriol (8-DHE3) and dehydro-pregnanetriol (7-DHPT), and methods of their synthesis | HSD17B3, HSD17B13, HSD17B11 | USP2 2994/4885MEN1 880/4885KMT2A 4343/4885 |
| US-20250319190-A1 | APOE LIPOPROTEIN SYSTEMS | APOB, APOL1, LDLR | USP2 2046/4885MEN1 3385/4885KMT2A 4008/4885 |
| US-20200109163-A1 | CARBONATED BEVERAGE AND METHOD FOR CARBONATION ENHANCEMENT | CA9, CA2, CA4 | USP2 3490/4885MEN1 581/4885KMT2A 1460/4885 |
| US-20020013302-A1 | Meiosis regulating compounds | CYP11A1, NR5A1, MNS1 | USP2 4073/4885MEN1 851/4885KMT2A 3180/4885 |
| US-20040048838-A1 | Meiosis regulating compounds | CYP11A1, NR5A1, MNS1 | USP2 4073/4885MEN1 851/4885KMT2A 3180/4885 |
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | STUB1, SAMM50, CD14 | USP2 806/4885MEN1 4321/4885KMT2A 4140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.